AxoGen, Inc. (NASDAQ:AXGN), a leading medical technology company focused on the $1.6 billion U.S. peripheral nerve repair market, announced that it has been selected from a record number of applicants as a presenting company at the 2014 Conference of the Southeastern Medical Device Association (SEMDA). AxoGen, Inc. (NASDAQ:AXGN) weekly performance is 11.79%. On last trading day company shares ended up $2.75. Analysts mean target price for the company is $6.17. AxoGen, Inc. (NASDAQ:AXGN) distance from 50-day simple moving average (SMA50) is -11.47%.
Emergent Biosolutions (NYSE:EBS) was upgraded by Zacks from a “neutral” rating to an “outperform” rating in a note issued to investors on Wednesday, Analyst Ratings Network reports. The firm currently has a $28.60 price target on the stock. Zacks‘s price target would indicate a potential upside of 14.17% from the company’s current price. Emergent Biosolutions Inc (NYSE:EBS) shares fell -9.26% in last trading session and ended the day on $22.73. Emergent Biosolutions Inc (NYSE:EBS) Gross Margin is 80.10% and its return on assets is 5.40%. Emergent Biosolutions Inc (NYSE:EBS) quarterly performance is -5.29%.
Research analysts at Deutsche Bank upped their price target on shares of Radnet (NASDAQ:RDNT) to $7.00 in a report released on Friday, Analyst Ratings Net reports. Deutsche Bank’s target price points to a potential upside of 31.58% from the stock’s previous close. RadNet Inc. (NASDAQ:RDNT) shares moved up 21.80% in last trading session and was closed at $6.48, while trading in range of $ 5.20 – 6.74. RadNet Inc. (NASDAQ:RDNT) year to date (YTD) performance is 288.02%.
Dynatronics Corporation (DYNT) announced results for its fiscal second quarter ended December 31, 2013. Net income for the quarter was $44,095 ($.02 per common share), compared to $140,983 ($.06 per common share) for the prior year period. Net loss for the six-month period ended December 31, 2013, was $63,689 ($.03 per common share), compared to net income of $89,839 ($.04 per common share) for the prior year period. Net sales in the quarter decreased to $7,146,787, compared to $7,998,319 in the same period of the prior year. Net sales in the six months ended December 31, 2013, decreased to $14,202,215, compared to $15,204,345 in the same period of the prior year. Dynatronics Corporation (NASDAQ:DYNT) ended the last trading day at $3.07. Company weekly volatility is calculated as 2.59% and price to cash ratio as 19.31. Dynatronics Corporation (NASDAQ:DYNT) showed a positive weekly performance of 4.25%.
Leave a Reply